Lipid-lowering therapy for secondary prevention in patients undergoing elective percutaneous coronary intervention (PCI)
Study identifier:NIS-CSI-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Terminated/Withdrawn
Official Title
LIPID-LOWERING THERAPY FOR SECONDARY PREVENTION IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION (PCI) A 10-week, open-label, non-interventional study of total cholesterol/LDL-cholesterol management in real life in coronary patients hospitalised for elective PCI
Medical condition
Coronary artery disease
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
120
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Mar 2011
Study Completion Date: 01 Mar 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Vojko Kanic
University Clinical Centre Maribor
